| Oxidative stability in lipid formulations: a review of the mechanisms, drivers, and inhibitors of oxidation J Musakhanian, JD Rodier, M Dave AAPS PharmSciTech 23 (5), 151, 2022 | 46 | 2022 |
| Effect of lipid vehicles on solubility, stability, and topical permeation of delta-9-tetrahydrocannabinol VK Shankar, A Shettar, S Rangappa, I Ellis, M Dave, R Murthy, SN Murthy AAPS PharmSciTech 23 (6), 223, 2022 | 3 | 2022 |
| An experimental approach to determine the solubility and factors affecting the solubility of poorly soluble drugs in polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol … MU Dave Long Island University, The Brooklyn Center, 2018 | 1 | 2018 |
| Transforming Liquid SEDDS into Solid Oral Dosage Forms J Musakhanian, M Ellis, Inayet and Dave American Pharmaceutical Review https://www.americanpharmaceuticalreview …, 2022 | | 2022 |
| Development of Delta-9-Tetrahydrocannabinol and Cannabidiol Self-Emulsifying Formulations: Challenge Tests to Assess the Stability of Formulations SN Murthy, I Ellis, M Dave American Association of Pharmaceutical Sciences - Poster Presentation, 2021 | | 2021 |
| Solubility and Stability of Delta-9-Tetrahydrocannabinol in Lipid Excipients VK Shankar, A Shettar, P Kolimi, I Ellis, M Dave, R Murthy, N Murthy Controlled Release Society - Poster presentation, 2021 | | 2021 |
| Key Considerations for Stabilizing Oxidation-Prone Lipid-Based Drug Delivery Systems D Langbein, M Dave American Pharmaceutical Review, 2021 | | 2021 |
| A Quick Approach for Evaluation of Drug-Excipient Compatibility: Case of Acetylsalicylic Acid https://drug-dev.com/whitepapers/130832/ M Dave, R Fuller, J Le Pree https://drug-dev.com/whitepapers/130832/ Drug Development & Delivery, 2021 | | 2021 |
| A novel ODT or chewable dosage form for acetaminophen: an isoleucine prodrug approach Z Wu, P Bhavsar, M Dave, X Yuan, D Wang Pharmacy & Pharmacology International Journal 8 (6), 345-350, 2020 | | 2020 |
| TAM Technique for Identifying API-Lipid Excipient Compatibility Issues Upstream in the Development Process M Dave, J Le Pree American Association of Pharmaceutical Sciences - Poster Presentation, 2018 | | 2018 |
| A systematic approach to formulate and evaluate the stability of topical creams with high concentrations of Transcutol ® HP M Dave, J Le Pree American Association of Pharmaceutical Sciences - Poster Presentation, 2018 | | 2018 |
| A Systematic Approach to Lipid-Based Formulation Development for a Poorly Soluble API, Fenofibrate M Dave, J Le Pree American Association of Pharmaceutical Sciences - Poster Presentation, 2017 | | 2017 |
| Investigation of the mechanisms responsible for solubility of poorly soluble drugs in Soluplus using two thermodynamic models and comparing the results M Dave, RA Bellantone American Association of Pharmaceutical Sciences - Poster Presentation, 2016 | | 2016 |
| Experimental determination of the solubility and factors influencing the solubility of Indomethacin in Soluplus at elevated temperatures. M Dave, RA Bellantone American Association of Pharmaceutical Sciences - Poster Presentation, 2015 | | 2015 |
| In vitro evaluation of the release of Diltiazem Hcl from HPMC gels: Effects of certain enhancers on diffusion through cellulose membrane and human cadaver skin M Dave, FM Plakogiannis American Association of Pharmaceutical Sciences - Poster Presentation, 2012 | | 2012 |
| Effects of the concentration of certain permeation enhancers on the permeation of Diltiazem HCl through cellulose membrane and human cadaver skin MU Dave Long Island University, The Brooklyn Center, 2011 | | 2011 |
